PTSD

How does ketamine therapy work for PTSD?

Research suggests that ketamine therapy for PTSD may work by acting on the glutamate system in the brain, which stimulates neuroplasticity—the growth of new neural connections¹. When people live with PTSD, their brains can become locked in patterns of hypervigilance, intrusive memories, and heightened threat response. Ketamine therapy may help interrupt these rigid patterns by enabling the brain to form new, healthier connections that support more adaptive responses to triggers and perceived threats.

Traditional PTSD treatments like SSRIs work by adjusting serotonin levels over weeks or months², while therapy approaches like prolonged exposure can require many sessions and face dropout rates of approximately 25-40%⁴. Ketamine works through an entirely different mechanism, rapidly enhancing the brain's flexibility and capacity for change. In Mindbloom's analysis, some clients reported feeling noticeably calmer and more capable of processing traumatic experiences within hours to days of their first session, with benefits that compound across multiple treatments when combined with comprehensive therapeutic support.

During ketamine sessions at therapeutic doses, clients often experience a sense of calm detachment from traumatic memories and distressing physical sensations. This creates an opportunity to observe trauma responses from a different perspective, recognizing them as mental events rather than imminent dangers. These insights, when properly integrated through coaching and reflection, help clients develop lasting tools for managing PTSD symptoms in daily life.

While research suggests these therapeutic mechanisms, the complete neurobiological pathways through which ketamine affects PTSD symptoms are still being studied, and ketamine therapy does not work for everyone.

Learn more: Safety information | Mindbloom outcomes | Legal status

How effective is ketamine therapy for PTSD?

Research suggests that ketamine therapy may be beneficial for PTSD³. In Mindbloom's preliminary real-world analysis of 374 clients with PTSD, 79% of participants reported meaningful improvement in their PTSD symptoms after completing six sessions. Additionally, 60% reported remission upon program completion.

What makes these results particularly significant is both the speed and strength of improvement. While traditional treatments like SSRIs typically require 8-12 weeks to show effects and may help only 30-60% of patients^2,5, 62% of Mindbloom clients reported clinically significant improvement after two sessions. In addition, Mindbloom clients reported an average symptom reduction of 44%. For context:

• Participants in a large randomized trial of prolonged exposure therapy reported 17% reduction in symptoms at the 6-week timepoint, with continued improvement to 36% at 24 weeks²
• Participants in studies of antidepressant medications reported up to 27% reduction in symptoms^2,5
• Participants in a published study of esketamine (Spravato) reported a 28% reduction in symptoms⁶

By combining ketamine's neuroplastic effects with clinician oversight, guide coaching, integration practices, and community support, clients receive tools and support for long-term symptom management. This holistic approach attempts to address not just immediate symptom relief but also the underlying patterns and triggers that perpetuate PTSD.

For individuals with treatment-resistant PTSD—those who haven't responded to at least two different first-line interventions—Mindbloom's ketamine therapy represents a valuable alternative that works through an entirely different mechanism than traditional treatments.

Learn more: Safety information | Mindbloom outcomes | Legal status

How quickly does ketamine therapy reduce PTSD symptoms?

Ketamine therapy may reduce PTSD symptoms more quickly than traditional treatments. According to Mindbloom's preliminary real-world analysis, 62% of clients achieved a clinically significant reduction in PTSD symptoms after two sessions—typically within the first two weeks of starting treatment.

This speed represents a notable difference from conventional approaches:

• SSRIs for PTSD typically require 8-12 weeks before showing effects^2,5
• Prolonged exposure therapy often requires 8-15 weekly sessions before meaningful improvement³
• Even when traditional treatments do work, many people experience partial relief rather than full remission

The cumulative response trajectory from Mindbloom's preliminary analysis shows continued improvement across six sessions:

• 62% response rate after Session 2 (weeks 1-2)
• 74% response rate after Session 4 (weeks 3-4)
• 79% response rate after Session 6 (weeks 4-6)

For those experiencing suicidal ideation alongside PTSD, the speed of relief can be particularly meaningful. Eight in ten clients who began treatment with suicidal thoughts reported improvement in suicidal thoughts within their first two sessions, with three in four reporting resolution by program completion.

It's important to note that while many clients notice rapid initial improvements, sustained recovery may be supported by ongoing integration work. The neuroplastic changes facilitated by ketamine may create windows of opportunity for healing, but lasting transformation may benefit from actively working with those insights between sessions.

Important: If you are experiencing suicidal thoughts, please contact the 988 Suicide & Crisis Lifeline immediately. Ketamine therapy is not FDA-approved for suicidal ideation and should only be considered as part of comprehensive psychiatric care with appropriate safety protocols.

Learn more: Safety information | Mindbloom outcomes | Legal status

What results can I expect from ketamine therapy for PTSD?

Results from ketamine therapy for PTSD can vary by individual, but data from Mindbloom's preliminary real-world analysis provides context for potential outcomes. After completing six sessions with Mindbloom, most clients reported improvements in trauma symptoms, including reduced intrusive thoughts, fewer nightmares, decreased hypervigilance, and an improved ability to engage with daily activities and relationships.

The timeline for results can be relatively rapid compared to traditional treatments. In Mindbloom's preliminary analysis, 62% of clients reported meaningful improvement after just two sessions, with that number growing to 79% by program completion.

Many describe experiencing reduced emotional reactivity to triggers, better sleep quality, and a renewed sense of safety in their everyday lives.
In addition, Mindbloom’s preliminary analysis also showed improvement in suicidal ideation, which affects many people with PTSD. Among the subset of clients who began treatment reporting suicidal thoughts (based on internal data, not peer-reviewed):

• 83% reported some improvement after just two sessions
• 76% reported resolution of suicidal thoughts upon program completion

After completing an initial program, about three-fifths of clients reported remission from PTSD symptoms, as measured by the PCL-5 assessment (a validated, widely-used clinical tool for measuring PTSD severity).

Individual experiences varied based on factors including trauma history, symptom severity, and engagement with integration practices between sessions. Some clients noticed shifts within hours of their first session, while others observed gradual improvements that build across multiple treatments.

Important: Ketamine therapy is not FDA-approved for treating suicidal ideation. If you are experiencing suicidal thoughts, please contact the 988 Suicide & Crisis Lifeline immediately or seek emergency care. Ketamine therapy should only be considered as part of comprehensive psychiatric care with appropriate safety monitoring.

Learn more: Safety information | Mindbloom outcomes | Legal status

How do I get started with ketamine therapy for PTSD?

Getting started with Mindbloom's ketamine therapy for PTSD is straightforward:

1. Complete a brief online assessment to share information about your symptoms and medical history
2. Schedule a consultation with a licensed Mindbloom clinician who will evaluate your eligibility
3. Begin your first guided session with support from your clinical team and guide
4. Receive your personalized treatment plan if ketamine therapy is appropriate for you
5. Get your medication delivered to your door with all necessary supplies

Throughout your treatment, you'll have access to continuous clinical oversight, guide coaching, and integration support to help you get the most from your experience.
‍
If you're ready to explore whether ketamine therapy could help you move beyond PTSD, take our candidate assessment to take the first step toward meaningful recovery.

Learn more: Safety information | Mindbloom outcomes | Legal status

What does the Mindbloom program for PTSD include?

Mindbloom’s ketamine therapy program for PTSD is designed as a structured, clinician-guided experience that integrates medicine, preparation, and integration to support trauma recovery. The program includes:

Clinical care & monitoring

• An initial video consultation with a licensed psychiatric clinician to assess eligibility and personalize your treatment plan
• Ongoing clinical oversight throughout the program, with support available between sessions
• Adjustments to your protocol as needed, based on your progress and experience

Guided ketamine sessions

• 6, 12, or 18 ketamine sessions, completed at home over several weeks
• A dedicated digital platform (the Mindbloom App) to support your sessions with intention-setting tools, therapeutic soundscapes, and real-time guidance
• Choice between sublingual tablets or subcutaneous injectables

Integration & support

• One-on-one coaching sessions with a trained Mindbloom Guide
• Structured integration practices and exercises to help process insights between sessions
• Tools to capture reflections, including voice journaling
• Access to a private peer support community


Preparation & education

• A comprehensive onboarding process to prepare you for treatment
• Resources on topics like trauma healing, neuroplasticity, and ketamine therapy
• Guidance on how to create a supportive set and setting for at-home sessions


Mindbloom’s program is built to address both the biological and psychological dimensions of PTSD, with a focus on safety, structure, and support throughout the healing process.

How does at-home ketamine therapy compare to in-clinic treatments?

Mindbloom's at-home ketamine therapy protocol has demonstrated promising outcomes in preliminary analyses.

‍Effectiveness data:

According to Mindbloom's preliminary real-world analysis of PTSD outcomes, the symptom reduction achieved with at-home treatment was comparable to results from the largest published study of IV ketamine therapy for PTSD.¹² Mindbloom clients showed a 44% average reduction in PTSD symptom severity, which represents clinically meaningful improvement. Some early response measures showed faster improvement trajectories with Mindbloom clients reporting 29% symptom reduction after two sessions vs 28% for IV ketamine, though direct comparisons should be interpreted cautiously given differences in study design and populations.

‍Accessibility & affordability:‍

• At-home ketamine therapy through Mindbloom typically costs significantly less than in-clinic IV ketamine infusions, which can range from $400-$800+ per session at many clinics based on a survey of ketamine clinic pricing in October 2025
• No need to travel to a clinic or take time off work
• Treatment available across the United States, not just in major cities

‍Comfort & therapeutic benefit:

For people with PTSD, who often experience hypervigilance and discomfort in unfamiliar settings, the ability to undergo sessions in a familiar, safe home environment may enhance treatment tolerability and engagement. While controlled studies directly comparing outcomes by treatment setting are limited, the concept of 'set and setting'—that environment influences psychedelic experiences—is well-established in the research literature¹³.

‍Comprehensive support:

Mindbloom's model includes guide coaching, structured preparation and integration, and ongoing clinical monitoring alongside ketamine treatment. Published research on psychedelic-assisted therapy suggests that therapeutic support and integration practices may be important factors in treatment outcomes¹³.

The choice between at-home and in-clinic treatment is personal. Some people prefer the structure of a clinical setting, while others find the comfort of home more conducive to deep therapeutic work. What matters most is finding an approach that feels right for you and provides comprehensive support for your healing.

Learn more: Safety information | Mindbloom outcomes | Legal status

What if ketamine therapy doesn't work for me?

While clinical research shows high response rates, ketamine therapy doesn't work for everyone. If you don't experience meaningful improvement, Mindbloom's clinical team will work with you to explore alternative treatment options or adjustments to your protocol. The goal is always to find an approach that supports your healing.

Does ketamine therapy help with PTSD-related anxiety and depression?

Yes, ketamine therapy may help with the anxiety and depression that often accompany PTSD. In Mindbloom's preliminary real-world PTSD analysis (based on internal data, not peer-reviewed), among the 374 clients who completed treatment:

• 94% of clients with comorbid anxiety reported improvement, with 73% achieving clinically significant symptom reduction
• 95% of clients with comorbid depression reported improvement, with 78% achieving clinically significant symptom reduction

This is particularly important because PTSD rarely exists in isolation. Many people with PTSD also struggle with anxiety disorders, major depressive disorder, or both. By targeting neuroplastic mechanisms associated with trauma processing, Mindbloom's approach to ketamine therapy may reduce the interconnected symptoms that make PTSD so debilitating.

Traditional treatments often require separate interventions for PTSD, anxiety, and depression, which can mean multiple medications or therapy protocols. Ketamine therapy's ability to address multiple conditions simultaneously through neuroplasticity represents a different approach—one that recognizes how trauma impacts mental health holistically.

Learn more: Safety information | Mindbloom outcomes | Legal status

Who is a good candidate for ketamine therapy for PTSD?

Ketamine therapy for PTSD through Mindbloom may be appropriate for adults who:‍

• Have been diagnosed with PTSD or meet diagnostic criteria
• Are seeking an alternative to traditional treatments or haven't found adequate relief from SSRIs or therapy
• Are willing to engage actively in integration work between sessions
• Can commit to a structured 4-6 week treatment program
• Have a safe, comfortable space at home for sessions

‍Ketamine therapy may be particularly valuable for people who:‍

• Experience treatment-resistant PTSD (defined as not achieving adequate symptom relief after at least two evidence-based first-line interventions, such as SSRIs or trauma-focused psychotherapy)
• Struggle with anxiety and depression alongside PTSD
• Experience suicidal ideation related to trauma
• Have difficulty tolerating the side effects of traditional medications
• Need faster relief than conventional treatments can provide
• Are motivated to do deep therapeutic work and process difficult emotions

‍You may not be a candidate if you:‍

• Have uncontrolled hypertension or certain cardiovascular conditions
• Have a history of psychotic disorders
• Are currently struggling with active substance use disorders
• Are pregnant or breastfeeding
• Have certain other medical or psychiatric conditions that could increase risk

The best way to determine if ketamine therapy is right for you is through a comprehensive evaluation with a Mindbloom clinician. During your initial consultation, a licensed medical provider will review your medical and psychiatric history, current symptoms, treatment history, and personal goals to assess whether ketamine therapy is appropriate and safe for your situation.

Every person's experience with PTSD is unique. Mindbloom's clinical team is committed to matching you with the treatment approach that offers the best potential for meaningful recovery.

Learn more: Safety information | Mindbloom outcomes | Legal status

Is ketamine therapy safe for PTSD treatment?

Ketamine therapy has an established safety profile when administered with proper medical oversight. Ketamine has been used in medical settings since 1970, accumulating over 50 years of clinical experience.⁷ When used at therapeutic doses for mental health treatment, ketamine therapy produces a different side effect profile than traditional antidepressants. The most common effects include temporary dissociation (altered perception), blood pressure elevation, and nausea, which typically resolve within hours of the session.⁸

In Mindbloom's clinical studies, 95% of clients completed their treatment course, with only 0.3% discontinuing due to side effects^9,10. Among clients who did experience side effects, the most common were mild and temporary, including nausea or dizziness that resolved within hours of the session. This discontinuation rate differs from SSRIs, where side effects such as weight gain, sexual dysfunction, and emotional blunting may cause some people to stop treatment.¹¹

The safety of Minbloom’s at-home ketamine therapy is supported by comprehensive clinical protocols. Before beginning treatment, clients undergo medical evaluation to ensure eligibility. Throughout the program, licensed clinicians actively monitor progress, adjust dosing as needed, and remain available for consultations. Sessions are conducted at home in a comfortable environment with safety protocols in place, and clients have access to 24/7 support. This level of oversight, combined with proper dosing and administration, makes ketamine therapy a valuable option for many people with PTSD.

Ketamine therapy is not appropriate for individuals with uncontrolled hypertension, history of psychotic disorders, active substance use disorders, certain cardiovascular conditions, or those who are pregnant or breastfeeding.

Learn more: Safety information | Mindbloom outcomes | Legal status

Is ketamine therapy FDA-approved for PTSD?

Ketamine is FDA-approved as an anesthetic but is prescribed off-label for PTSD treatment by licensed clinicians based on clinical judgment and a growing body of research evidence. Off-label prescribing is a common and legal medical practice—studies estimate that 20% of all prescriptions in the U.S. are for off-label uses.

How is ketamine therapy different from Spravato?

Spravato (esketamine nasal spray) is an FDA-approved treatment specifically for treatment-resistant depression and requires in-clinic administration twice weekly during the initial phase. Ketamine therapy through Mindbloom differs in several ways:

• Administration route: Sublingual tablets or subcutaneous injections vs. nasal spray
• Setting: At-home treatment vs. required in-clinic administration
• Medication type: Racemic ketamine (both R- and S-ketamine) vs. esketamine (S-ketamine only)
• Support structure: Comprehensive preparation, integration, and guide coaching throughout treatment

Both ketamine and esketamine act on similar neurobiological pathways. Published analyses of esketamine in patients with comorbid PTSD have shown varying outcomes depending on study populations and protocols.⁶ Mindbloom's preliminary analysis showed favorable results in the context of comprehensive therapeutic support, though direct comparisons across different treatment models and study designs should be interpreted cautiously.

Can I continue my current medications during ketamine therapy?

In most cases, yes. Many clients continue their existing psychiatric medications during ketamine therapy. However, certain medications may need to be adjusted or temporarily paused. Your Mindbloom clinician will review all your current medications during your consultation and provide guidance specific to your situation.

Does insurance cover ketamine therapy for PTSD?

Currently, most insurance plans do not cover ketamine therapy for PTSD as it is prescribed off-label. However, Mindbloom offers flexible payment options and our costs are often significantly lower than in-clinic IV ketamine. Treatment with Mindbloom is also often HSA/FSA eligible, although this should be confirmed with the plan administrator.